Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 USD | -1.45% | -0.73% | -40.50% |
Apr. 17 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
Apr. 11 | European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.50% | 21.59M | |
+3.62% | 43.43B | |
+47.81% | 41.69B | |
+9.08% | 41.31B | |
-10.92% | 27.14B | |
+8.79% | 25.28B | |
-25.02% | 18.47B | |
+29.35% | 12.59B | |
+0.76% | 12.33B | |
+8.60% | 11.03B |
- Stock Market
- Equities
- EVAX Stock
- News Evaxion Biotech A/S
- Transcript : Evaxion Biotech A/S, Q2 2022 Earnings Call, Aug 10, 2022